Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1998-05-13
2000-01-25
Achutamurthy, Ponnathapu
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
4352523, 435325, 4353201, 435 691, 536 231, C12Q 168, C12Q 2106, C12N 1500, C12N 500, C07H 2102
Patent
active
060177101
ABSTRACT:
The invention features polynucleotides encoding novel GTP-binding polypeptides, hereinafter referred to as RAQ polypeptides; expression vectors comprising a RAQ polynucleotide of the invention; isolated cells comprising a RAQ-encoding vector; a transgenic non-human animal comprising an alteration in a RAQ gene; and the use of RAQ polynucleotides in detecting in an individual the presence of a genetic polymorphism of a RAQ gene. The invention further features novel RAQ polypeptides; monoclonal antibodies specific for RAQ polypeptides; and a method for making RAQ polypeptides.
REFERENCES:
Bos, J.L., "ras Oncogenes in Human Cancer: A Review," Cancer Res. 49:4682-4689 (Sep. 1, 1989).
Hatta, et al., "Ovarian Cancer Has Frequent Loss of Heterozygosity at Chromosome 12p 12.3-13.1 (Region of TEL and Kip 1 loci) and Chromosomes 12q23-ter: Evidence for two New Tumour Suppressor Genes," British Journal of Cancer 75(9):1256-1262 (1997).
Johansson, et al., "Cytogenetic Deletion Maps of Hematologic Neoplasms: Circumstantial Evidence for Tumor Suppressor Loci," Genes, Chromosomes& Cancer 8(4): 205-218 (Dec. 1993).
Manenti, et al., "Association of Chromosome 12p Genetic Polymorphisms with Lung Adenocarcinoma Risk and Prognosis," Carcinogenesis 18(10): 1917-1920 (Oct. 1997).
Symons, Marc, "The Rac and Rho Pathways as a Source of Drug Targets for Ras-Mediated Malignancies," Current Opinion in Biotechnology 6:668-674 (1995).
Zachos, et al. "Expression of ras Proto-Oncogenes: Regulation and Implications in the Development of Human Tumors,"Crit. Rev. Oncol. Hematol. 26(2):67-75 (1997).
Genbank accession No. AA031734, May 9, 1997.
Genbank accession No. AA131239, May 14, 1997.
Genbank accession No. AA437054, May 30, 1997.
Genbank accession No. AA663946, Nov. 12, 1997.
Genbank accession No. AA769749, Feb. 8, 1998.
Genbank accession No. AA782027, Feb. 5, 1998.
Genbank accession No. N98847, Apr. 10, 1996.
Genbank accession No. D62865, May 21, 1996.
Genbank accession No. AA742672, Jan. 22, 1998.
Genbank accession No. H01201, Jun. 19, 1995.
Genbank accession No. R40247, May, 22, 1995.
Genbank accession No. D62925, May 21, 1996.
Genbank accession No. H01299, Jun. 19, 1995.
Genbank accession No. D79833, Dec. 15, 1995.
Genbank accession No. Z19345, Sep. 21, 1995.
Genbank accession No. AA037415, May 10, 1997.
Genbank accession No. D79915, Dec. 15, 1995.
Genbank accession No. AA663274, Nov. 12, 1997.
Genbank accession No. F00427, Sep. 21, 1995.
Genbank accession No. AA564698, Sep. 5, 1997.
Genbank accession No. R14297, Apr. 12, 1995.
Genbank accession No. AA214398, Mar. 12, 1998.
Genbank accession No. R55855, May 23, 1995.
Genbank accession No. AA131358, May 14, 1997.
Genbank accession No. M31468, Jun. 15, 1990.
Genbank accession No. Y07565, Dec. 2, 1996.
Genbank accession No. U71203, Feb. 7, 1997.
Genbank accession No. X15014, Sep. 12, 1993.
Genbank accession No. X08004, Jul. 6, 1989.
Genbank accession No. Z14134, Mar. 31, 1995.
Genbank accession No. J04160, Sep. 15, 1989.
Allen Maxine J.
Buckler Alan J.
Rutter Marc
Achutamurthy Ponnathapu
AxyS Pharmaceuticals, Inc.
Francis Carol L.
Monishipouri M.
LandOfFree
RAQ genes and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with RAQ genes and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and RAQ genes and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2314920